altimmune glp-1 Altimmune's Drug Reduces Heavy Drinking in Alcohol-Use Disorder Trial. Altimmune's pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide pemvidutide vs tirzepatide Effect of
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18





























